Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Seed Co Ltd/Tokyo (7743 JP)
Watchlist
14
Analysis
Health Care
•
Japan
SEED CO., LTD. manufactures and sells contact lenses and contact lens care products. The Company also manufactures lenses for eye glasses, frames, medical instruments, and ultrasound-wave-cleaners for eye glasses.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Public Financial
•
14 Sep 2026 01:21
Merger Arb Mondays (14 Sep) - Public Financial, Skyworth, Changhong Jiahua, Z Fin, OFX, Cleanaway
I summarise the latest spreads and newsflow for the merger arb situations covered across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
Arun George
Follow
166 Views
Share
bearish
•
Quantitative Analysis
•
09 Sep 2026 18:45
JPX Margin Trading Weekly (Sep 4th): Kioxia, SoftBank, Advantest, Fujikura, Mitsubishi UFJ Financial
We analyzed JPX margin trading positions report for the past week and highlighted Kioxia (285A JP), SoftBank (9984 JP), Advantest (6857 JP),...
Ke Yan, CFA, FRM
Follow
112 Views
Share
bullish
•
Skyworth
•
07 Sep 2026 02:19
Merger Arb Mondays (07 Sep) - Skyworth, Z Fin, OFX, Cleanaway, EQT, European Lit, BetMakers, Kakaku
I summarise the latest spreads and newsflow for the merger arb situations covered across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
Arun George
Follow
199 Views
Share
bullish
•
Kakaku.com Inc
•
30 Aug 2026 06:19
Weekly Deals Digest (30 Aug) - Kakaku, Dentsu Soken, Seed, Carnaby, Peet, Suncorp, OUE, Shein
A weekly summary of key developments in ECM and Event-Driven names that I track in Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia,...
Arun George
Follow
105 Views
Share
bullish
•
Shanghai Conant Optical
•
22 Aug 2026 10:34
Conant Optical (2276 HKG): 1H26 Revenue and Margins Expand; XR Lenses Growth Story Slowly Unfolding
In 1H26, Shanghai Conant reported revenue rise of 8% YoY to RMB 1.2B. Demand outlook, expansion plans, R&D initiatives and margin strength offer a...
Tina Banerjee
Follow
109 Views
Share
Previous
1
2
3
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x